HSBC Holdings’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$841K Buy
15,466
+6,767
+78% +$322K ﹤0.01% 1959
2025
Q4
$325K Sell
8,699
-9,249
-52% -$376K ﹤0.01% 2496
2025
Q3
$727K Buy
17,948
+2,686
+18% +$88.7K ﹤0.01% 1925
2025
Q2
$389K Sell
15,262
-1,778
-10% -$38.8K ﹤0.01% 2294
2025
Q1
$363K Sell
17,040
-669
-4% -$15K ﹤0.01% 2258
2024
Q4
$372K Buy
17,709
+6,169
+53% +$143K ﹤0.01% 2361
2024
Q3
$260K Sell
11,540
-2,290
-17% -$44.2K ﹤0.01% 2445
2024
Q2
$238K Buy
+13,830
New +$222K ﹤0.01% 2447
2022
Q4
Sell
-11,780
Closed -$159K 3155
2022
Q3
$159K Sell
11,780
-3,934
-25% -$67.9K ﹤0.01% 2687
2022
Q2
$299K Sell
15,714
-485
-3% -$9.19K ﹤0.01% 2628
2022
Q1
$327K Buy
+16,199
New +$327K ﹤0.01% 2696

Other funds holding PAHC

HSBC Holdings's PAHC Position: Q1 2026 in Review

HSBC Holdings increased its Phibro Animal Health (PAHC) stake by 78% in Q1 2026, buying an estimated $322K and bringing the position to 15,466 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.

HSBC Holdings first reported a position in PAHC in Q1 2022 and has held it in 11 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • HSBC Holdings held 15,466 shares of Phibro Animal Health worth $841K as of Q1 2026.
  • HSBC Holdings bought 6,767 Phibro Animal Health shares in Q1 2026, an estimated $322K.
  • Phibro Animal Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1959 holding.
  • HSBC Holdings first reported a position in Phibro Animal Health in Q1 2022 and has held it in 11 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.